A study focused on uncovering clinically significant aberrantly methylated genes in tumor cells reported three genes to be exclusively hypomethylated in TNBC, specifically Von Willebrand factor C and Epidermal Growth Factor domain-containing protein (VWCE), tetraspanin-9 (TSPAN9), and ADAM12. This evidence concerns the gene ADAM12 and neoplasm.